{"first_name":"Jan","last_name":"Rutherford","permalink":"jan-rutherford-2","crunchbase_url":"http://www.crunchbase.com/person/jan-rutherford-2","homepage_url":"","birthplace":"","twitter_username":null,"blog_url":"","blog_feed_url":"","affiliation_name":"Scottish Equity Partners","born_year":null,"born_month":null,"born_day":null,"tag_list":"","alias_list":null,"created_at":"Fri Mar 20 13:57:51 UTC 2009","updated_at":"Mon Mar 23 19:13:41 UTC 2009","overview":"<p>Jan Rutherford is a principal at SEP, focusing on therapeutics, specialty pharmaceuticals and contract pharmaceutical services. She led SEPâ€™s investment in the contract research organisation Cmed, which is deploying its proprietary Timaeus technology for the electronic capture and management of clinical trial data. </p>\n\n<p>Before joining SEP, Jan was with Dresdner Kleinwort Capitalâ€™s Life Science team in London, where she managed investments in biotechnology and medical device companies in Europe and the USA. Jan is a registered pharmacist and her previous background is in drug development and clinical research, working for Quintiles, Merck Sharp &amp; Dohme and Sandoz/Novartis. </p>","image":{"available_sizes":[[[150,150],"assets/images/resized/0003/8768/38768v2-max-150x150.jpg"],[[156,156],"assets/images/resized/0003/8768/38768v2-max-250x250.jpg"],[[156,156],"assets/images/resized/0003/8768/38768v2-max-450x450.jpg"]],"attribution":""},"degrees":[],"relationships":[{"is_past":false,"title":"Principal ","firm":{"name":"Scottish Equity Partners","permalink":"scottish-equity-partners","type_of_entity":"financial_org","image":{"available_sizes":[[[150,130],"assets/images/resized/0002/9935/29935v9-max-150x150.jpg"],[[250,217],"assets/images/resized/0002/9935/29935v9-max-250x250.jpg"],[[450,391],"assets/images/resized/0002/9935/29935v9-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}